Orion - Annual Financial Report

Orion Group Financial Statement documents 2013 and Corporate Governance Statement published

ORION CORPORATION        STOCK EXCHANGE RELEASE 3 MARCH 2014 at 1.10 p.m. EET



Orion Group Financial Statement documents 2013 and Corporate Governance
Statement published

Orion Group's Financial Statement documents for 2013 have been published. The
documents are available in Finnish and English on the Company's website at
http://www.orion.fi.

The official financial statement documents, which include the financial
statements, the report of the Board of Directors and the auditor's report are
available in Finnish at http://www.orion.fi/Orion/Yhtiokokoukset/Yhtiokokous-
2014/.

Orion's Corporate Governance Statement for year 2013, adopted by the Board of
Directors, is published as a separate report in Finnish and English on the
Company's website at http://www.orion.fi/.





Orion Corporation



 Olli Huotari                 Terhi Ormio
 SVP, Corporate Functions     VP, Communications







Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler® pulmonary drugs.

Orion's net sales in 2013 amounted to EUR 1,007 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.

[HUG#1765821]

Attachments:

Orion Corporate Governance Statement.pdf

Orion Financial Statement documents 2013.pdf